Important disclaimer: I am an AI assistant. This interpretation is for educational/informational purposes only and must NOT be used as a substitute for a formal radiological report by a qualified radiologist. Always correlate with clinical findings and consult the treating physician.

HRCT Thorax Interpretation

Film 1 - Mediastinal/Soft Tissue Window

• Heart and pericardium: Normal size and configuration; no pericardial effusion
• Great vessels: Aorta (ascending, arch, descending) normal caliber; no aneurysm or dissection
• Trachea and mainstem bronchi: Patent, midline, no endobronchial lesions

• No gross bulky mediastinal (paratracheal, subcarinal) or hilar lymphadenopathy
• No significant axillary adenopathy

• No pleural effusion bilaterally
• No pneumothorax
• No significant pleural thickening or plaques

• No large consolidations, lobar collapse, or obvious mass lesions
• Lung fields predominantly aerated without gross architectural distortion

• Liver: Homogeneous attenuation, no obvious focal lesions
• Spleen: Normal size and attenuation
• Stomach: Grossly unremarkable

• Ribs, sternum, visualized vertebrae intact; no lytic or blastic lesions

Film 2 - Lung Window (HRCT Cuts)

• Diffuse, bilateral, symmetric interlobular septal thickening
• Fine reticular opacities bilaterally
• Distribution: Predominantly mid-to-lower lung zones and subpleural regions
• This pattern is consistent with an Interstitial Lung Disease (ILD)

• Patchy, bilateral areas of ground-glass attenuation, more prominent in the lower lobes
• May represent active inflammation, early fibrosis, or partial air-space filling

• Dilated, thick-walled bronchi in the lower lobes bilaterally
• Indicates chronic fibrotic interstitial change

• A well-circumscribed, rounded nodular opacity in the right mid/lower lobe region
• Approximate size: ~1.5-2 cm
• Requires correlation with mediastinal window for calcification, fat content, or enhancement characteristics

• Mild fullness in subcarinal and bilateral hilar regions on lung windows
• Suggests possible reactive or inflammatory lymphadenopathy (needs mediastinal window confirmation)

Impression

1. Diffuse bilateral ILD pattern - septal thickening, reticular opacities, traction bronchiectasis, and patchy GGOs, predominantly lower lobe/subpleural distribution. The differential includes:
   • UIP (Usual Interstitial Pneumonia)/IPF - if predominantly basal, subpleural, with honeycombing
   • NSIP (Non-Specific Interstitial Pneumonia) - if GGO-predominant and symmetric
   • Hypersensitivity Pneumonitis
   • Connective tissue disease-associated ILD (e.g., RA, systemic sclerosis)
   • Sarcoidosis (if upper lobe predominance with lymphadenopathy)
2. Right lung nodule (~1.5-2 cm) - requires further characterization; differentials include granuloma, carcinoid, primary lung malignancy, or metastasis.
3. Possible reactive hilar/mediastinal lymphadenopathy.

Recommendations

• Correlation with clinical history: Occupational/environmental exposures, smoking history, autoimmune symptoms (joint pain, skin changes, sicca), medications, fever, travel history
• Pulmonary function tests (PFTs): To assess restrictive vs. obstructive pattern
• Serology: ANA, anti-dsDNA, RF, anti-Scl-70, anti-Jo-1 to screen for CTD-ILD
• Formal radiologist report: Dedicated review of mediastinal window for nodule characterization and lymph node sizing
• PET-CT or bronchoscopy/BAL may be warranted depending on clinical context for the right lung nodule
• MDT discussion (respiratory physician, radiologist, pathologist) if ILD diagnosis requires tissue biopsy

Management of Giddiness (Dizziness / Vertigo)

Step 1 - Define the Type of Dizziness

Step 2 - Peripheral vs Central Vertigo

Step 3 - Common Causes and Specific Management

A. Benign Paroxysmal Positional Vertigo (BPPV) - Most Common Cause

• The Epley maneuver uses gravity to move loose otoconia out of the posterior semicircular canal into the vestibule
• 4-5 sequential head rotations, hold each position ~30 seconds or until nystagmus/vertigo resolves
• Success rate: 50-90% (single maneuver); one large study of 965 patients showed 85% improvement
• Repeat DHT after 10 minutes - if negative, discharge without activity restrictions
• If still positive, repeat Epley; if unsuccessful twice, home exercises twice daily

• Diagnosed by supine roll test (pure horizontal nystagmus both sides)
• Treated with Gufoni maneuver (not Epley)
• Usually resolves spontaneously within days

B. Vestibular Neuritis (Viral Labyrinthitis)

• Sudden onset severe vertigo, nausea/vomiting lasting days
• No hearing loss (if hearing loss present = labyrinthitis)
• Spontaneous horizontal nystagmus toward unaffected ear

• Acute phase (first 24-72 hours): Vestibular suppressants + antiemetics
  • Prochlorperazine (Stemetil) 5-10 mg IM/oral - antiemetic + vestibular suppressant
  • Dimenhydrinate (Dramamine) or meclizine
  • Diazepam 2-5 mg if severe (short course only)
• Corticosteroids: Methylprednisolone may accelerate recovery (controversial but used)
• Limit suppressants to 72 hours - prolonged use delays central compensation
• Vestibular rehabilitation exercises as soon as tolerated

C. Meniere's Disease

• Triad: episodic vertigo (hours) + fluctuating sensorineural hearing loss + tinnitus + aural fullness

• Vestibular suppressants (as above for acute attacks)
• Bed rest in quiet environment

• Low-salt diet (<2 g/day sodium)
• Thiazide diuretics (hydrochlorothiazide 25 mg) - reduce endolymph volume
• Betahistine (8-16 mg TDS) - widely used, evidence variable
• Avoid caffeine, alcohol, stress

• Intratympanic gentamicin (chemical labyrinthectomy) - very effective, carries risk of hearing loss
• Intratympanic dexamethasone
• Endolymphatic sac surgery
• Vestibular nerve section (hearing preserved)

D. Vestibular Migraine

• Most common cause of episodic vertigo in adults (often underdiagnosed)
• Vertigo + migrainous headache or photophobia/phonophobia

E. Central Vertigo (Posterior Fossa Stroke/TIA)

• New onset headache with vertigo
• Normal head impulse test with nystagmus
• Vertical nystagmus, direction-changing nystagmus
• Any focal neurological signs (diplopia, facial numbness, limb weakness, ataxia, dysphagia)
• AICA infarct: vertigo + sudden hearing loss + facial weakness + ataxia

F. Other Causes - Specific Management

Step 4 - Vestibular Suppressant Drugs (When Indicated)

Step 5 - Vestibular Rehabilitation

• Indicated for all chronic or persistent vestibular disorders
• Cawthorne-Cooksey exercises: progressive head, eye and balance movements
• Goals: improve functional balance, reduce falls risk, decrease symptoms
• Supervised physiotherapy superior to home exercise alone

Step 6 - Older Adults - Special Considerations

• Dizziness in elderly = multifactorial (visual decline + proprioceptive loss + vestibular degeneration + polypharmacy)
• Increased risk of falls - systematic review confirms dizziness is associated with future falls [PMID 39293812]
• Review all medications (antihypertensives, sedatives, diuretics)
• Optimize vision
• Fall prevention: walking aids, home modification, strength/balance training

Summary Algorithm

Giddiness complaint
       |
Is it TRUE VERTIGO (spinning) or near-syncope/lightheadedness?
       |
   VERTIGO
       |
Positional (with head movement)?
  YES → Dix-Hallpike → BPPV → Epley maneuver
  NO  → Continuous/episodic spontaneous vertigo
            |
        RED FLAGS? → YES → MRI brain, stroke workup
        NO ↓
        Hearing loss? → YES → Meniere's / labyrinthitis
        NO → Vestibular neuritis / Vestibular migraine
            → Vestibular suppressants (short course)
            → Rehabilitation